NDC00074-6346-53: ERYTHROMYCIN STEARATE TABLETS.
The ERYTHROMYCIN STEARATE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: COATING FEATURE:NONENTERIC FILM, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 500.000 TABLETS, active_medicament_medicinal_strength: 250.000 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-102-8663, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | COATING FEATURE:NONENTERIC FILM |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 500.000 TABLETS |
| active_medicament_medicinal_strength | 250.000 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT |
| NSN | 6505-01-102-8663 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | COATING FEATURE:NONENTERIC FILM |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT |